September: Barcelona - Basel - Cambridge - Charleroi - London - Munich
Join our interactive Seminars at a range of locations across Europe this September.
Register now to find out how to advance your immunotherapy drug discovery by optimising the use of preclinical murine immuno-oncology models.
Understanding the differences between preclinical immuno-oncology models, and where each best fits into your integrated drug development program, is an essential part of immuno-oncology research. Correctly choosing, or progressing through, syngeneic, murine tumor homograft, and humanised drug target models enables you to save time and resources during preclinical development.
At these events you’ll have the chance to ask any immuno-oncology and preclinical drug development questions related to your studies, as well as time to network with peers.
There’ll also be a 1 hour presentation from Dr. Ludovic Bourré, Director of Scientific Engagement on ‘Murine Immuno-Oncology Models: From Syngeneics to Novel Tools to Address Human Specificity’.
Schedule of Events
|17th September||16:00||Charleroi||BE||Le new vintage, Rue du Petit Piersoulx 1, 6041 Charleroi, Belgique|
|18th September||10:00||Barcelona||ES||Parc Cientific de Barcelona, Carrer de Baldiri Reixac 12|
|19th September||14:00||Munich||DE||IZB Residence, Am Klopferspitz 21, 82152 Planegg/Martinsried|
|20th September||10:00||Cambridge||UK||Hardwick Room, Main Hall, Babraham Research Campus|
|20th September||15:00||London||UK||Uncommon, 1 Long Lane, Borough, SE1 4PG|
|21st September||10:00||Basel||CH||Hochbergerstr. 60c, 4057 Basel|
Attendance is free but space is limited.
Register now to reserve your seat!